SSSjoerd A. S. Stufkens

Sjoerd A. S. Stufkens

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sjoerd A. S. Stufkens has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Poor mental health in patients with symptomatic osteochondral lesions of the talus

    by Juliëtte H. M. Pijnacker, Nathanael O. Agyeman-Prempeh, Inger N. Sierevelt, Kaj S. Emanuel, Birit Broekman, Gino M. M. J. Kerkhoffs, Sjoerd A. S. Stufkens

    Aims: Osteochondral lesions of the talus (OLT) can cause pain and functional limitations, potentially affecting mental health. This study aimed to compare mental health in patients with OLT to the general Dutch population and individuals with mood or anxiety disorders, and to identify factors associated with mental health in OLT patients. Methods: This prospective study included patients with symptomatic OLT prior to treatment. Data for the general population and individuals with mood or anxiety disorders were obtained from the Netherlands Mental Health Survey and Incidence Study-3. Mental health was assessed using the Mental Health Inventory-5 (MHI-5). The primary outcome was the mean difference in MHI-5 between OLT patients and the general population. Multivariate linear regression examined associations between mental health and age, sex, BMI, smoking, lesion characteristics, laterality, and Foot and Ankle Outcome Score (FAOS) pain. Results: Among the 358 included OLT patients, 87% (311 of 358) scored ≤ 76 on the MHI-5. OLT patients scored significantly lower than the general population (mean difference 20.2 (95% CI 18.9 to 21.5)) and showed similar scores to individuals with a mood or anxiety disorder (mean difference 2.0 (95% CI -0.3 to 4.3)). One and two years after treatment, 79% (170/214) and 78% (134/173) of patients, respectively, scored ≤ 76 on the MHI-5. Multivariate analysis identified smoking (β = -2.6 (95% CI -4.7 to -0.4)) and FAOS pain (β = 0.3 (95% CI 0.1 to 0.3)) significantly associated with MHI-5 scores. Conclusion: Poor mental health is highly prevalent in patients with OLT, with scores substantially lower than the general population and comparable with individuals with mood or anxiety disorders. Smoking and ankle pain were associated with worse mental health. Despite successful long-term clinical outcomes of treatment of OLT, mental health remained poor. These findings underscore the importance of integrating mental health interventions alongside orthopaedic care for patients with OLT. Cite this article: Bone Joint J 2026;108-B(9):1147–1153.


  • Open Access

    Sex differences in osteochondral lesions of the talus: Lesion size reflects patients dimensions, whereas morphology differs between sexes

    by Arianna L. Gianakos, Juliëtte H.M. Pijnacker, Inger N. Sierevelt, Elze J. Geurts, Jari Dahmen, Robert Hemke, Sjoerd A.S. Stufkens, Gino M.M.J. Kerkhoffs

  • Osteochondral Lesions of the Talus

    by J. J. Hollander, J. A. H. Steman, Q. G. H. Rikken, J. Dahmen, S. A. S. Stufkens, G. M. M. J. Kerkhoffs

  • Open Access

    Understanding Pain in Osteochondral Lesions of the Talus: A Cross-Sectional, CT‑Based Analysis Showing Limited and Inconsistent Associations With Pain

    by Julian J. Hollander, Inger N. Sierevelt, Jason A. H. Steman, Juliëtte H. M. Pijnacker, Kaj S. Emanuel, Gino M. M. J. Kerkhoffs, Sjoerd A. S. Stufkens

    Background: Patients with an osteochondral lesion of the talus (OLT) often present with deep ankle pain, but the direct relationship between structural damage and the perceived pain remains unclear. The aim of this study was therefore to determine whether pain is associated with demographic and radiologic (computed tomography [CT]-only) lesion characteristics. Methods: This cross-sectional study was conducted in patients with symptomatic OLTs at a tertiary referral academic hospital. The primary outcome was the Pain subscale of the Foot and Ankle Outcome Score (FAOS). Secondary outcomes included the Numeric Rating Scale (NRS) for pain at rest and during walking, as well as the other FAOS subscales. Associations with patient demographics, lesion size, morphology, and location were assessed using univariate linear regression, followed by multivariate linear regression with backward selection. Results: A total of 310 patients were included. In the final multivariate model for the FAOS Pain subscale, higher age (β = −0.18, P = .04) and smoking (β = −8.70, P < .001) were significantly associated with worse pain scores. Lesion morphology characterized by the presence of an osteochondral fragment was associated with lower NRS pain scores during walking. For NRS pain at rest, worse scores were significantly associated with female sex, higher body mass index, smoking, non-primary lesion nature, and greater lesion depth. Conclusion: No association was found between CT-based radiologic lesion characteristics and patient-reported pain as measured by the FAOS Pain subscale. In secondary analyses, some lesion characteristics showed associations, but these were limited and directionally inconsistent. These findings suggest structural damage alone does not seem to fully explain the patient’s pain. Given the CT‑only approach and other design constraints, further research is warranted.


  • Open Access

    Arthroscopic Bone Marrow Stimulation for Non-primary Osteochondral Lesions of the Talus Yields Limited Improvements in Patient-Reported Outcomes Compared to Primary Lesions: A Prospective 2-Year Follow-up Study

    by Quinten G. H. Rikken, Jari Dahmen, Julian J. Hollander, Jason A. H. Steman, Sjoerd A. S. Stufkens, Gino M. M. J. Kerkhoffs

    Background: Our aim in this study was to prospectively assess the patient-reported clinical outcomes of arthroscopic bone marrow stimulation (BMS) for non-primary osteochondral lesions of the talus (OLT) and to compare these with primary cases at 2-year follow-up. The secondary aims were to assess the association of baseline factors with outcomes and the occurrence of adverse events. Methods: Patients who underwent arthroscopic BMS were prospectively included and assessed up to 2-year follow-up and were grouped according to non-primary (ie, failed previous OLT surgery) or primary BMS. Patient-reported outcomes were collected at baseline and 2-year follow-up and included the numeric rating scale (NRS) for pain and the Foot and Ankle Outcome Score (FAOS) questionnaires. The primary outcome was the improvement in NRS pain during walking, with a minimal clinically important difference (MCID) of 2.0. Adverse events concerned reoperations and complications during the study period. Results: Forty-four patients were included: 25 in the primary group and 19 in the non-primary group. Both groups showed a statistically significant improvement in pain and functional outcomes from preoperatively to 2-year follow-up. The improvement in the primary outcome was significantly higher in the primary group (median 3 [IQR: 1-5] out of 10) compared to the non-primary group (median 1 [IQR: 1-3] out of 10), P = .01. Moreover, 68% (95% CI 46%-85%) reached the MCID compared with 32% (95% CI 13%-57%) in the non-primary group, which was statistically significant ( P = .03). Baseline variables showed no consistent association with the primary outcome, except for a moderate correlation with age and lower improvements for patients who received concomitant surgery in the primary group. None of the changes in the FAOS sub-scales showed a statistically significant difference between the two groups. Two revision procedures (non-primary group: 11% [95% CI 1%-33%] vs 0% primary group, P = .2) occurred in the non-primary group. During the study period, 1 case (non-primary group: 5% [1%-26%] vs primary group: 0%, P = .4) had a complication. Conclusion: The most important finding of this prospective study is that arthroscopic BMS for non-primary OLT yields a significant improvement in patient-reported outcomes compared with baseline, but an inferior improvement compared with primary OLT at 2-year follow-up. On average, approximately two-thirds of BMS-treated primary OLTs reached the MCID compared with one-third in the non-primary group. Level of Evidence: Level II, prospective comparative cohort study.


  • Open Access

    Sustained Improvement in Pain with Talar OsteoPeriostic Grafting from the Iliac Crest (TOPIC) for Medial Osteochondral Lesions of the Talus

    by Julian J. Hollander, Jari Dahmen, Sjoerd A.S. Stufkens, Gino M.M.J. Kerkhoffs

    Talar OsteoPeriostic grafting from the Iliac Crest (TOPIC) for large osteochondral lesions of the medial talar dome was shown to be effective at 2 years of follow-up. In this prospective cohort study, our aim was to evaluate the clinical and radiographic outcomes at 5 years of follow-up. The primary outcome was the Numeric Rating Scale (NRS) score for pain during walking. Secondary outcomes included NRS scores for pain during rest and during stair-climbing as well as scores on the Foot and Ankle Outcome Score (FAOS) subscales, Short Form (SF)-36 Physical Component Summary and Mental Component Summary scores, and the American Orthopaedic Foot & Ankle Society (AOFAS) ankle-hindfoot score. Computed tomography (CT) scans were evaluated. Thirty-seven patients were included. Two patients died and 2 underwent ankle arthrodesis before 5 years and thus were not included in the 5-year statistical analysis of outcomes. The median NRS score for pain during walking improved from 7 (interquartile range [IQR], 5 to 8) preoperatively to 2 (IQR, 1 to 4) at 5 years (p < 0.001), surpassing the minimal clinically important difference. All secondary clinical outcomes improved significantly. All grafts showed incorporation, and 87% of the patients with a CT scan at 5 years demonstrated evidence of cyst formation. Osteoperiosteal autografting using the TOPIC technique is an effective treatment option for large medial osteochondral lesions of the talus, with durable results at 5 years of follow-up. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.


  • Open Access

    Immediate Postoperative Weightbearing Following Arthroscopic Bone Marrow Stimulation for Talar Osteochondral Lesions: A Matched Cohort Study

    by Tristan M. F. Buck, Jari Dahmen, Quinten G. H. Rikken, Julian J. Hollander, Sjoerd A. S. Stufkens, Gino M. M. J. Kerkhoffs

    Background: Bone marrow stimulation (BMS) is the most frequently performed surgical procedure for osteochondral lesions of the talus (OLTs). After the surgical intervention, one of the first goals of rehabilitation is to resume weightbearing. This study aims to compare clinical and radiologic outcomes between immediate weightbearing and delayed weightbearing, which represent unrestricted weightbearing and weightbearing starting at 6 weeks postoperatively. Methods: All patients who underwent BMS for their OLT between July 2019 and September 2022 in our clinic were screened for eligibility. Patients were retrospectively included with prospective collected data and were matched into 2 groups, the immediate weightbearing group or the delayed weightbearing group. The following variables were used for matching: age, gender, side, lesion size (volume and surface measured on CT scans), primary or nonprimary lesion, body mass index (BMI) and the numeric rating scale (NRS) of pain during walking. The primary outcome of this study is the comparison of the change in NRS of pain during walking between baseline and 12 months postoperatively, between both groups. Secondary outcomes consist of change in the NRS of pain during running, NRS pain during stairclimbing, NRS pain during rest, 36-Item Short Form Health Survey, Foot and Ankle Outcome Score, return to work, return to sport, and radiologic outcomes between both groups at 12 months. Results: After matching, 13 patients per group were included. Both groups showed improvement in NRS pain during walking from baseline to 12 months postoperatively. The difference in change scores between immediate and delayed weightbearing was not statistically significant ( P = .57, 95% CI −3.25 to 1.86). A higher proportion of patients in the immediate weightbearing group exceeded the minimal clinically important difference threshold of 2 points compared with the delayed group (OR = 1.9, 95% CI 0.30-11.7), although this was not statistically significant. No significant between-group differences were observed in secondary clinical or radiologic outcomes, nor in return-to-work or return-to-sport rates. Conclusion: This matched cohort study found no statistically significant difference in clinical or radiologic outcomes at 12 months between immediate and delayed weightbearing following arthroscopic BMS for talar osteochondral lesions. Although early weightbearing may be feasible and well tolerated, the small sample size and wide CIs limit the strength of conclusions. These findings should be considered hypothesis-generating and underscore the need for larger, prospective trials.

  • Foot Stress Fractures

    by Julian J. Hollander, Jari Dahmen, Sjoerd A. S. Stufkens, Gino M. M. J. Kerkhoffs

  • Open Access

    Talar OsteoPeriostic Grafting From the Iliac Crest (TOPIC): Prospective 2-Year Outcomes for Large Lateral Osteochondral Lesions of the Talus

    by Julian J. Hollander, Kaj S. Emanuel, Jari Dahmen, Gino M. M. J. Kerkhoffs, Sjoerd A. S. Stufkens

    Background: The results of the Talar OsteoPeriostic grafting from the Iliac Crest (TOPIC) procedure for lateral osteochondral lesions of the talus (OLTs) are unknown. Therefore, the present prospective study aims to assess the numeric rating scale (NRS) of pain during walking at 2-year follow-up. Secondarily, the aim is to assess other clinical, radiologic, and safety outcomes. Methods: This is a single-center, nonrandomized prospective cohort study in which all press-fit lateral TOPIC patients for an OLT are included. Patients with a follow-up of at least 2 years without a concomitant osteochondral lesion of the tibial plafond were included. The primary outcome is the NRS of pain during walking. Secondary clinical outcomes included the NRS during rest and during stair climbing. Additionally, the Foot and Ankle Outcome Score (FAOS), the AOFAS ankle-hindfoot score, and the mental and physical component summary of the 36-Item Short Form Health Survey were recorded. Radiologic follow-up was performed using computed tomography (CT) scans. Results: After application of the inclusion and exclusion criteria, 7 patients were included in the present study. The median age at time of surgery was 31.1 years. The NRS of pain during walking improved from a median of 5 (4-7) preoperatively to 1 (0-1) at 2 years of follow-up ( P = .02). All FAOS subscales improved significantly, except the FAOS symptoms subscale. Graft consolidation was observed in 100% of the patients and cysts were present in 5 of 6 patients. No complications occurred and no patients complained of donor site morbidity. No reoperations were performed. Conclusion: In the first 7 prospectively followed patients who underwent the TOPIC procedure for large osteochondral lesions of the lateral talar dome, an improvement of the NRS of pain during walking from median 5 preoperatively to 1 at 2-year follow-up was observed.


  • Open Access

    Nonoperative Treatment for Osteochondral Lesions of the Talus Provides Clinical Improvement in the Minority of the Patients at Short-term Follow-up

    by Tristan M. F. Buck, Jason A. H. Steman, Jari Dahmen, Quinten G. H. Rikken, Inger N. Sierevelt, Sjoerd A. S. Stufkens, Gino M. M. J. Kerkhoffs

    Background: Often, the preferred initial treatment for osteochondral lesions of the talus (OLTs) is nonoperative for at least 6 months before considering more invasive surgical strategies. The primary aim of this study was to evaluate the clinical effectiveness of nonoperative management for OLTs on prospective clinical outcomes over a 1-year period. Secondary aims included assessing the radiologic outcomes, the rate of conversion to surgery, and the influence of baseline factors on return to a higher level of activity. Methods: Patients who underwent nonoperative management for primary OLTs were prospectively included. Clinical outcome measures were assessed at baseline, 6 months, and 12 months. The primary outcome of this prospective cohort study is the change in the numeric rating scale (NRS) for pain score during walking between baseline and 12 months. Secondary outcomes included changes in NRS during rest, NRS during running, NRS during stair climbing, Foot and Ankle Outcome Scale (FAOS) subscales, changes in lesion volume and surface area, and conversion to surgery rate. Results: A total of 40 patients (42 ankles) mean age 31.6 years with a primary symptomatic OLT were included. The primary outcome, NRS during walking, significantly improved between 0 and 12 months (4.8 to 3.3; P = .0003). However, the mean decrease did not exceed the minimal clinically important difference (MCID), with only 38% of the patients exceeding the MCID at 12-month follow-up. NRS scores during running and stair climbing showed improvements from baseline to 6 months ( P = .0004 and P = .002) and from baseline to 12 months ( P = .0001 and P = .0002). None of these average NRS change scores at 12-month follow-up exceeded the MCID. FAOS sports and quality of life subscales improved significantly from baseline to 6 months ( P = .003 and P = .011) and remained stable from 6 to 12 months. The FAOS pain subscale showed significant improvement only after 12 months. Lesion sizes remained stable throughout the one-year period. Conclusion: Nonoperative treatment resulted in statistically significant improvements in pain during walking after 1 year, with clinically relevant improvement observed in 38% of patients. These findings suggest that nonoperative treatment held the potential for meaningfully improving symptoms in the minority of our patients, with no appreciable change in OLTT size. We think it should be considered as a preferred approach for the first line of treatment.